1. Home
  2. SCLX vs FOSL Comparison

SCLX vs FOSL Comparison

Compare SCLX & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$10.98

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

HOLD

Current Price

$3.62

Market Cap

209.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
FOSL
Founded
2011
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
209.2M
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
SCLX
FOSL
Price
$10.98
$3.62
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
77.6K
419.4K
Earning Date
11-14-2025
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,360,000.00
$1,066,179,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$0.86
52 Week High
$34.27
$4.40

Technical Indicators

Market Signals
Indicator
SCLX
FOSL
Relative Strength Index (RSI) 35.63 47.15
Support Level $10.35 $3.66
Resistance Level $13.83 $4.01
Average True Range (ATR) 0.94 0.24
MACD 0.01 -0.05
Stochastic Oscillator 25.24 10.17

Price Performance

Historical Comparison
SCLX
FOSL

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.

Share on Social Networks: